Deferoxamine blocks death induced by glutathione depletion in PC 12 cells

NeuroToxicology

Volumn 37, Issue , 2013, Pages 221-230

  Chouraqui, E ^a   Leon, A ^a   Repesse, Y ^a   Prigent Tessier, A ^b   Bouhallab, S ^c   Bougle, D ^d   Marie, C ^b   Duval, D ^a  

^a GIP CYCERON   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c UMR1253   (France)

^d CHU Clemenceau   (France)

Author keywords

Glutathione depletion and cell death; Iron chelators; Neuroprotection; Oxidative stress

Indexed keywords

BUTHIONINE SULFOXIMINE; CASEIN; COPPER; DEFEROXAMINE; FERRITIN; GLUTATHIONE; IRON; PHOSPHOPEPTIDE; SODIUM; ZINC;

APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE TRANSPORT; CELL METABOLISM; CELL PROTECTION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; HOMEOSTASIS; IRON TRANSPORT; NEUROPROTECTION; OXIDATIVE STRESS; PC12 CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BUTHIONINE SULFOXIMINE; CYTOPROTECTION; DEFEROXAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; HOMEOSTASIS; IRON; IRON CHELATING AGENTS; NEURONS; PC12 CELLS; RATS; TIME FACTORS;

EID: 84879232277     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2013.04.013     Document Type: Article

References (83)

1. Ait-Oukhatar N., Peres J.M., Bouhallab S., Neuville D., Bureau F., Bouvard G., Arhan P., Bougle D. Bioavailability of caseino-phosphopeptide-bound iron. J Lab Clin Med 2002, 140:290-294.
2. Arosio P., Levi S. Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim Biophys Acta 2010, 1800:783-792.
3. Arrigo A.P. Gene expression and the thiol redox state. Free Rad Biol Med 1999, 27:936-944.
4. Bains J.S., Shaw C.A. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Rev 1997, 25:335-358.
5. Barañano D.E., Snyder S.H. Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc Natl Acad Sci USA 2001, 98:10996-11002.
6. Barath S., Andersen J.K. Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson's disease. Antiox Redox Signal 2005, 7:900-910.
7. Barath S., Hsu M., Kaur D., Rajagopalan S., Andersen J.K. Glutathione, iron and Parkinson's disease. Biochem Pharmacol 2002, 64:1037-1048.
8. Batistatou A., Greene L.A. Aurintricarboxylic acid rescue PC 12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity. J Cell Biol 1991, 115:461-471.
9. Ben-Shachar D., Eshel G., Finberg J.P.M., Youdim M.B.H. The iron chelator desferrioxamine (desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J Neurochem 1991, 56:1441-1444.
10. Berg D., Gerlach M., Youdim M.B.H., Double K.L., Zecca L., Riederer P., Becker G. Brain iron disease and their relevance to Parkinson's disease. J Neurochem 2001, 79:225-236.
11. Bishop G.M., Robinson S.R., Liu Q., Perry G., Atwood C.S., Smith M.A. Iron: a pathological mediator of Alzheimer disease. Dev Neurosci 2002, 24:184-187.
12. Biswas S., Chida A.C., Rahman I. Redox modifications of protein thiols: emerging roles in cell signalling. Biochem Pharmacol 2006, 71:551-564.
13. Bossy-Wetzel E., Schwarzenbacher R., Lipton S.A. Molecular pathways to neurodegeneration. Nat Med 2004, 52-59.
14. Callapina M., Zhou J., Schnitzer S., Metzen E., Lohr C., Deitmer J.W., Brune B. Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1 alpha accumulation Implications for prolylhydroxylase activity and iron. Exp Cell Res 2005, 15:274-284.
15. Chen K., Gunter C., Maines M.D. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem 2000, 75:304-313.
16. Cooper A.J.L., Kristal B.S. Multiples roles of glutathione in the central nervous system. Biol Chem 1997, 378:793-802.
17. Demougeot C., Van Hoecke M., Bertrand N., Prigent-Tessier A., Mossiat C., Beley A., Marie C. Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2'-dipyridyl in the rat photothrombotic ischemic stroke model. J Pharmacol Exp Ther 2004, 311:1080-1087.
18. Di Monte D.A., Chen P., Sandy M.S. Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage. Ann Neurol 1992, 32:S111-S115.
19. Dore S., Takahashi M., Ferris C.D., Hester L.D., Guastella D., Snyder S.H. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA 1999, 96:2445-2450.
20. Dwyer B.E., Lu S.Y., Laitinen J.T., Nishimura R.N. Protective properties of tin and manganese-centered porphyrins against hydrogen peroxide-mediated injury in rat astroglial cells. J Neurochem 1998, 71:2497-2504.
21. Erdö S.L., Michler A., Wolff J.R., Tytko H. Lack of excitotoxic cell death in serum-free cultures of rat cerebral cortex. Brain Res 1990, 526:328-332.
22. Ewing J.F., Maines M.D. Glutathione depletion induced heme oxygenase-1 (HSP 32) mRNA and protein in rat brain. J Neurochem 1993, 60:1512-1519.
23. Faa G., Crisponi G. Iron chelating agents in clinical practice. Coord Chem Rev 1999, 184:291-310.
24. Farinelli S.E., Greene L.A. Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC 12 cells and postmitotic sympathetic neurons after removal of trophic support. J Neurosci 1996, 16:1150-1162.
25. Ferris C.D., Jaffrey S.R., Sawa A., Takahashi M., Brady S.D., Barrow R.K., Tysoe S.A., Wolosker H., Barañano D.E., Dore S., Poss K.D., Snyder S.H. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1999, 152-157.
26. Froissard P., Duval D. Cytotoxic effects of glutamic acid on PC 12 cells. Neurochem Int 1994, 24:485-493.
27. Froissard P., Monrocq H., Duval D. Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC 12 cells. Eur J Pharmacol 1997, 326:93-99.
28. Ghibelli L., Coppola S., Fanelli C., Rotilio G., Civitareale P., Scovassi A.I., Ciriolo M.R. Glutathione depletion causes cytochrome c release even in the absence of cell commitment to apoptosis. FASEB J 1999, 13:2031-2036.
29. Hara M.R., Snyder S.H. Cell signaling and neuronal death. Annu Rev Pharmacol Toxicol 2007, 47:117-141.
30. Howard M.K., Burke L., Mailhos C., Pizzey A., Gilbert C.S., Lawson W.D., Collins M.K.L., Thomas N.S.B., Latchman D.S. Cell cycle arrest of proliferating neuronal cells by serum deprivation can result in either apoptosis or differentiation. J. Neurochem 1993, 60:1783-1791.
31. Hüttemann M., Pecina P., Rainbolt M., Sanderson T.H., Kagan V.E., Samavati L., Doan L., Lee I. The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: from respiration to apoptosis. Mitochondrion 2011, 11:369-381.
32. Immenschuh S., Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol 2000, 60:1121-1128.
33. Jenner P., Olanow W. Understanding cell death in Parkinson's disease. Ann Neurol 1998, 44:S72-S84.
34. Jha N., Jurma O., Lalli G., Liu Y., Pettus E.H., Greenamyre J.T., Liu R.M., Forman H.J., Andersen J.K. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity Implications for Parkinson's disease. J Biol Chem 2000, 275:26096-26101.
35. Kadoya C., Domino E.F., Yang G.Y., Stern J.D., Lorris-Betz A.L. Preischemic but not postischemic zinc protoporphyrin treatment reduces infarct size and edema accumulation after temporary focal cerebral ischemia in rats. Stroke 1995, 26:1035-1038.
36. Kaur D., Andersen J.K. Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility. Aging Cell 2002, 1:17-21.
37. Kaur P., Aschner M., Syversen T. Glutathione modulation influences methylmercury-induced neurotoxicity in primary cell cultures of neurons and astrocytes. Neurotoxicol 2006, 27:492-500.
38. Kaur D., Lee D., Ragapolan S., Andersen J.K. Glutathione depletion in immortalized midbrain-derived dopaminergic neurons results in increases in the labile iron pool: implications for Parkinson's disease. Free Rad Biol Med 2009, 46:593-598.
39. Kibangou I.B., Bouhallab S., Henry G., Bureau F., Allouche S., Blais A., Guerin P., Arhan P., Bougle D. Milk proteins and iron absorption: contrasting effects of different caseino-phosphopeptides. Pediatr Res 2005, 58:731-734.
40. Kim H.P., Ryter S.W., Choi A.M.K. CO as a cellular signalling molecule. Annu Rev Pharmacol Toxicol 2006, 46:411-449.
41. Kupershmidt L., Weinreb O., Amit T., Mandel S., Carri M.T., Youdim M.B.H. Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis. FASEB J 2009, 23:3766-3779.
42. Kurz T., Leake A., von Zglinick T., Brunck U.T. Relocalized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage. Biochem J 2004, 378:1039-1045.
43. Kurz T., Terman A., Gustafsson B., Brunck U.T. Lysosomes in iron metabolism, ageing and apoptosis. Histochem Cell Biol 2008, 129:389-406.
44. Lamb N.J., Quinlan G.J., Mumby S., Evans T.W., Gutteridge J.M. Haem oxygenase shows pro-oxidant activity in microsomal and cellular systems, implications for the release of low molecular-mass iron. Biochem J 1999, 344:153-158.
45. Le Foll I., Duval D.P. Programmed cell death induced by glutathione depletion in PC 12 cells is blocked by inhibitors of 12 lipoxygenase, but does not appear to be mediated through the formation of 12 HETE derivatives. Free Rad Biol Med 2001, 30:793-802.
46. Leon A., Le Foll I., Charriault-Marlangue C., Leprince J., Vaudry H., Gabriel C., Duval D. The level of heme oxygenase does not obligatorily reflect the sensitivity of PC 12 cells to an oxidative shock induced by glutathione depletion. J. Neurochem 2003, 64:459-470.
47. Li Y., Maher P., Schubert D. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 1997, 19:453-463.
48. Lucas J.H., Wheeler D.G., Emery D.G., Mallery S.R. The endogenous antioxidant glutathione as a factor in the survival of physically injured mammalian spinal cord neurons. J Neuropathol Exptl Neurol 1998, 57:937-954.
49. Mackenzie E.L., Iwasaki K., Tsuji Y. Intracellular iron transport and storage: from molecular mechanisms to health implication. Antiox Redox Signaling 2008, 10:997-1029.
50. Maher P. The effects of stress and aging on glutathione metabolism. Ageing Res Rev 2005, 4:288-314.
51. Mayer M., Noble M. N-acetyl-l-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci USA 1994, 91:7496-7500.
52. Mesner P.W., Epting C.L., Hegarty J.L., Green S.H. A timetable of events during programmed cell death induced by trophic factor withdrawal from neuronal PC12 cells. J Neurosci 1995, 15:7357-7366.
53. Moriarty-Craige S.E., Jones D.P. Extracellular thiols and thiol/disulfide redox in metabolism. Annu Rev Nutr 2004, 24:481-509.
54. Morozova N., Khrapko K., Panee J., Liu W., Harney J.W., Berry M.J. Glutathione depletion in hippocampal cells increases levels of H and L ferritin and glutathione S-transferases mRNAs. Genes Cells 2007, 12:561-567.
55. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
56. Murphy T.H., Miyamoto M., Sastre A., Schnaar R.L., Coyle J.T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 1989, 2:1547-1558.
57. Nakamura T., Lipton S.A. Redox modulation by S-nitrosylation contribute to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative disease. Cell Death Differ 2011, 8:1478-1486.
58. Nimura T., Weinstein P.R., Masa S.M., Panter S., Sharp F.R. Heme oxygenase-1 (HO-1) protein induction in rat following focal ischemia. Mol Brain Res 1996, 37:201-208.
59. Panahian N., Yoshiura M., Maines M.D. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J Neurochem 1999, 72:1187-1203.
60. Pantopoulos K. Iron metabolism and the IRE/IRP regulatory system. Ann N.Y. Acad Sci 2004, 1012:1-13.
61. Pearce R.K.B., Owen A., Daniel S., Jenner P., Marsden C.D. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J Neural Transm 1997, 104:661-677.
62. Petrat F., de Groot H., Rauen U. Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocyte and liver endothelial cells. Biochem J 2001, 356:61-69.
63. Ponka P. Cellular iron metabolism. Kidney Int 1999, 35:S2-S11.
64. Ratan R.R., Lee P.J., Baraban J.M. Serum deprivation inhibits glutathione depletion-induced death in embryonic cortical neurons: evidence against oxidative stress as a final common mediator of neuronal apoptosis. Neurochem Int 1996, 29:153-157.
65. Sagara Y., Dargusch R., Chambers D., Davis J., Schubert D., Maher P. Cellular mechanisms of resistance to chronic oxidative stress. Free Rad Biol Med 1998, 24:1375-1389.
66. Sarco D.P., Becker J., Palmer C., Sheldon R.A., Ferriero D.M. The neuroprotective effect of deferoxamine in the hypoxic-ischemic immature mouse brain. Neurosci Lett 2000, 282:113-116.
67. Schenck J.F., Zimmerman E.A. High-field magnetic resonance imaging of brain iron: birth of a biomarker. NMR Biomed 2004, 17:433-445.
68. Schipper H.M. Neurodegeneration with brain iron accumulation - clinical syndromes and neuroimaging. Biochim Biophys Acta 2012, 1822:350-360.
69. Selim M.H., Ratan R.R. The role of iron neurotoxicity in ischemic stroke. Ageing Res Rev 2004, 3:345-353.
70. Shimani E., Armon R., Neeman I. Antioxidant properties of deferoxamine. JAOCS 1994, 71:641-644.
71. Sian J., Dexter D.T., Lees A.J., Daniel S., Jenner P., Marsden C.D. Glutathione-related enzymes in brain in Parkinson's disease. Ann Neurol 1994, 36:356-361.
72. Sims N.R., Muyderman H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta 2010, 1802:80-91.
73. Tait S.W., Green D.R. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev - Mol Cell Biol 2010, 11:621-632.
74. Tan S., Schubert D., Maher P. Oxytosis: a new form of programmed cell death. Curr Top Med Chem 2001, 1:517-526.
75. Tanji K., Imaizumi T., Matsumiya T., Itaya H., Fujimoto K., Cui X.F., Toki T., Ito E., Yoshida H., Wakabayashi K., Satoh K. Desferioxamine an iron chelator, upregulates cyclooxygenase-2 expression and prostaglandin production in a human macrophage cell line. Biochim Biophys Acta 2001, 1530:227-235.
76. Terman A., Gustafsson B., Brunck U.T. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chemico-Biol Inter 2006, 163:29-37.
77. Tietze F. Enzymatic method for quantitative determination of total and oxidized glutathione. Anal Biochem 1969, 27:502-522.
78. Vimard F., Saucet M., Nicole O., Feuilloley M., Duval D. Toxicity induced by cumene hydroperoxide in PC 12 cells: protective role of thiol donors. J Biochem Mol Toxicol 2011, 25:205-215.
79. White A.R., Cappai R. Neurotoxicity from glutathione depletion is dependent on extracellular trace copper. J Neurosci Res 2003, 71:889-894.
80. Yu Z., Persson H.L., Eaton J.W., Brunck U.T. Intralysosomal iron: a major determinant of oxidant-induced cell death. Free Rad Biol Med 2003, 34:1243-1252.
81. waf1/cip1, and erythropoietin. J Neurosci 1999, 19:9821-9830.
82. Zecca L., Youdim M.B.H., Riederer P., Connor J.R., Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004, 5:863-873.
83. Zukor H., Song W., Liberman A., Mui J., Vali H., Fillebeen C., Pantopoulos K., Wu T.D., Guerquin-Kern J.L., Schipper H.M. HO-1 mediated macroautophagy: a mechanism for unregulated iron deposition in aging and degenerating neural tissues. J Neurochem 2009, 109:776-791.